lunularin has been researched along with 2-phenoxyphenol in 2 studies
| Studies (lunularin) | Trials (lunularin) | Recent Studies (post-2010) (lunularin) | Studies (2-phenoxyphenol) | Trials (2-phenoxyphenol) | Recent Studies (post-2010) (2-phenoxyphenol) |
|---|---|---|---|---|---|
| 14 | 1 | 11 | 6 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, Y; Kuroda, T; Matsuno, K; Miyachi, H; Morita, D; Okazaki, M; Sawada, H | 1 |
| Fujii, K; Kuroda, T; Miyachi, H; Morita, D; Onoda, K | 1 |
2 other study(ies) available for lunularin and 2-phenoxyphenol
| Article | Year |
|---|---|
Riccardin C derivatives as anti-MRSA agents: structure-activity relationship of a series of hydroxylated bis(bibenzyl)s.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Ethers, Cyclic; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2012 |
Minimum structural requirements for cell membrane leakage-mediated anti-MRSA activity of macrocyclic bis(bibenzyl)s.
Topics: Anti-Bacterial Agents; Cell Membrane Permeability; Macrocyclic Compounds; Methicillin-Resistant Staphylococcus aureus | 2016 |